| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 生物法长链二元酸(元) | 1,500,451,660.41 | 2,669,829,088.01 | 1,314,447,998.72 | 1,907,824,135.63 | 939,316,605.68 |
| 生物基聚酰胺及单体(元) | 65,847,612.42 | 144,308,671.29 | 78,552,275.53 | 154,245,225.16 | 69,756,922.58 |
| 其他(元) | 101,321,749.24 | 4,934,731.09 | 48,155,776.11 | 4,934,741.89 | 21,356,450.69 |
| 营业成本(元) | |||||
| 生物法长链二元酸(元) | 861,449,626.36 | 1,609,642,678.27 | 797,583,870.56 | 1,185,469,182.45 | - |
| 生物基聚酰胺及单体(元) | 70,892,703.77 | 167,172,328.18 | 93,285,954.36 | 181,996,913.27 | - |
| 其他(元) | 172,178,606.86 | 109,149,165.00 | 101,715,128.14 | 102,119,968.92 | - |
| 毛利(元) | |||||
| 生物法长链二元酸(元) | 639,002,034.05 | 1,060,186,409.74 | 516,864,128.16 | 722,354,953.18 | - |
| 生物基聚酰胺及单体(元) | -5,045,091.35 | -22,863,656.89 | -14,733,678.83 | -27,751,688.11 | - |
| 其他(元) | -70,856,857.62 | -104,214,433.91 | -53,559,352.03 | -97,185,227.03 | - |
| 毛利率(%) | |||||
| 生物法长链二元酸(%) | 42.59 | 39.71 | 39.32 | 37.86 | - |
| 生物基聚酰胺及单体(%) | -7.66 | -15.84 | -18.76 | -17.99 | - |
| 其他(%) | -69.93 | -2,111.86 | -111.22 | -1,969.41 | - |
| 收入构成(%) | |||||
| 生物法长链二元酸(%) | 89.98 | 94.71 | 91.21 | 92.30 | 91.16 |
| 生物基聚酰胺及单体(%) | 3.95 | 5.12 | 5.45 | 7.46 | 6.77 |
| 其他(%) | 6.08 | 0.18 | 3.34 | 0.24 | 2.07 |
| 毛利构成(%) | |||||
| 生物法长链二元酸(%) | 113.48 | 113.62 | 115.22 | 120.91 | - |
| 生物基聚酰胺及单体(%) | -0.90 | -2.45 | -3.28 | -4.65 | - |
| 其他(%) | -12.58 | -11.17 | -11.94 | -16.27 | - |